drugset / Trial / NCT02021266

Single Patient Expanded Access Protocol: Metabolic Boost

NCT02021266 ↗

Expanded access No longer available Talaris Therapeutics Inc. Duke University · collab

Summary

This is a single patient expanded access protocol to investigate the effects of a second dose of facilitating cell-enhanced hematopoietic stem cell product.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Enriched Hematopoetic Stem Cell Infusion Cell therapy — —